Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules. - Wikidata - wikimedia - TriplyDB

Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.

Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.

http://www.wikidata.org/entity/Q37172939

about

Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects Xanthine oxidoreductase in cancer: more than a differentiation marker Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation Cadmium exposure and its association with serum uric acid and hyperuricemia.Renal lipid metabolism and lipotoxicity.Chemistry meets biology in colitis-associated carcinogenesis Quercetin Protects against Cadmium-Induced Renal Uric Acid Transport System Alteration and Lipid Metabolism Disorder in Rats.The renal phenotype of allopurinol-treated HPRT-deficient mouse.Uric acid as a target of therapy in CKD.Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation.Uric acid secretion from adipose tissue and its increase in obesity Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.Molecular biology of atherosclerosis.Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma.Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.Xanthine oxidoreductase mediates membrane docking of milk-fat droplets but is not essential for apocrine lipid secretion.Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.

P2860

Q26773007-59070A86-ACD5-4BD4-AFAE-C76EC09D801D Q26774676-C8211970-BD23-4C25-B50B-01B52BD9C339 Q28354735-56DA539C-3326-4F70-862A-BDF42CA26AF8 Q28480520-3447047C-5A97-4C30-99B1-0B93CCA37A7E Q28483790-9F0167D2-77E1-4E91-938B-F2A7334F42AD Q33674377-BCB561DC-D771-422B-9A8C-80FAED82364A Q34825296-4687A2A1-9545-4F5D-844B-A1FB65A96DDA Q35047726-92C22D6B-4336-4FC9-8A17-37622682C18A Q36012033-0DBBF2B7-DC33-4FBC-BB28-0C7E0AEBBB21 Q36304281-19948DC9-BC4E-4E71-9E10-54618D39CB1C Q36476464-50DE9B34-FA16-452C-A604-9E13DFFA1906 Q36791027-7971EA96-AB2E-459D-A478-87D82B8DA845 Q37189456-7AE9542A-5C7D-4CF2-862F-F1C245CA83EA Q37903030-55259AC0-7194-4E5C-BA91-AAD1C6DFEF94 Q38125279-2D0C404F-D857-4658-A64C-4F1154C9FD4A Q42288267-931AEE7F-BE2A-4EF9-8F45-F675FA6C5DFC Q43199666-B8DBEEC7-5044-41CB-B396-D0A179D5D07A Q48181517-A4FCB607-73F8-4FE4-A4F6-58BF537CFC68 Q48772823-FF748DF7-56CA-42FA-AEE3-02151FDCC804

P2860

Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.

http://www.wikidata.org/entity/Q37172939

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@en

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@nl

type

label

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@en

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@nl

prefLabel

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@en

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@nl

P1433

Q37172939-CC08AD98-5EAC-4CDB-B8E2-674FA8D15E2D

P1476

Q37172939-9E52A213-328B-4A66-B90D-6D8FFE970306

P2093

Q37172939-236D8565-4D4F-4E16-994B-50500B9BD794

Q37172939-7A99FF74-5667-44F3-8015-6C9794C49AAA

Q37172939-88E09E9E-4440-4E8C-82C6-85867D45640F

Q37172939-905D3C3D-53DF-42A3-9EF6-619A1B49FB1F

Q37172939-976C0740-DAD3-40FE-839C-DFE2E73A381C

Q37172939-9C1B895D-800C-4C5D-B303-F58272933379

Q37172939-D0C731CC-7CD7-45FF-9C85-2F06CA64C622

Q37172939-D82DF369-B4B0-41DE-B545-1CD1CB9AAAC6

Q37172939-FD32BC8C-C9B9-4ABA-ABB3-292372C80748

P2860

Q37172939-027C4B9C-59F8-4E81-B9CC-C4EAF8A06598

Q37172939-02A8296B-3F0B-45C1-A80F-374FA601EE05

Q37172939-065DDA23-B9E8-4CA3-BD60-08CCFFDDAA82

Q37172939-1EAF08DD-CAF7-449F-AE81-8824BE7143A8

Q37172939-1EE38E0E-BA37-4128-B9A2-1B284FEB642A

Q37172939-1F8E7253-D02A-4F87-B816-4C6C4B112FC9

Q37172939-245D3AB4-EB5C-4DA5-BF0B-12E2B64AC382

Q37172939-25E80A03-17A7-4577-8DAB-B89E397E9E41

Q37172939-4ACE7E4B-198A-45B3-91BF-6BD52774CEC4

Q37172939-4C758B3A-A9A6-4619-947E-87D0E03779C3

P304

Q37172939-EA818DA7-268D-43F8-9EEF-9330B264DBE5

P31

Q37172939-CA283B4E-D9B6-432F-922E-1C46CF4A5579

P356

Q37172939-84F47C9A-FA5F-443F-9002-FAA957ECCA21

P407

Q37172939-2E99F134-A268-4CA6-B522-C5A97E0CB58C

P433

Q37172939-8644C7BE-2ACC-445C-BCD0-271270B413DE

P478

Q37172939-36FCE849-E2A7-40BD-B192-247EF806839F

P577

Q37172939-D6D7B6CB-B30D-414C-91C9-AEB165167A49

P5875

Q37172939-CB4A2D86-8636-405C-AC8B-B4198AD91190

P698

Q37172939-244C03F6-B3FA-4555-9CD7-B110A0548DF0

P932

Q37172939-87ADEE91-D6CB-4930-8D35-62EB7D6163D6

P356

HYPERTENSIONAHA.109.135152

P1433

P1476

Xanthine oxidoreductase deplet ...... accumulation in renal tubules.

@en

P2093

Hideko Noguchi

http://www.w3.org/2001/XMLSchema#string

Ilsa I Rovira

http://www.w3.org/2001/XMLSchema#string

Kanae Sakagami

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Tsuruya

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Matsumura

http://www.w3.org/2001/XMLSchema#string

Koji Fujii

http://www.w3.org/2001/XMLSchema#string

Mitsuo Iida

http://www.w3.org/2001/XMLSchema#string

Toren Finkel

http://www.w3.org/2001/XMLSchema#string

Toshio Ohtsubo

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity

Superoxide radicals in feline intestinal ischemia

Xanthine oxidoreductase is central to the evolution and function of the innate immune system

Accumulation of 8-oxo-deoxyguanosine in cardiovascular tissues with the development of hypertension

Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria

P304

868-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.135152

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26729095

http://www.w3.org/2001/XMLSchema#string

P698

19667249

http://www.w3.org/2001/XMLSchema#string

P932

3773720

http://www.w3.org/2001/XMLSchema#string